The abstract states that mitochondrial dysfunction alters the balance between osteogenesis and osteoclast activity under pathological conditions, but the precise molecular pathways linking mitochondrial quality control defects to bone cell imbalance remain unexplained. Understanding these mechanisms is critical for developing targeted mitochondrial therapies for osteoporosis. Gap type: unexplained_observation Source paper: Mitochondrial quality control and its role in osteoporosis. (2023, Frontiers in endocrinology, PMID:36793284)
Landscape Summary: What are the specific molecular mechanisms by which mitochondrial dysfunction disrupts osteoblast-osteoclast balance in osteoporosis? is a 0.6 priority gap in cellular-metabolism. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the specific molecular mechanisms by which mitochondrial dysfunction disrupts osteoblast-osteoclast balance in osteoporosis? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: